Daily Online Shopping Plunges 57% as Shoppers Return to the Certainty of Stores

BOSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) — Daily online shopping frequency has dropped sharply, falling from 21% to 9% in the past year as shoppers pull back from fast online purchases and lean more heavily on physical stores for confidence and value. This shift reflects rising prices, global trade strain, and growing trust gaps in […]

Free Live Sports Elevates Its Unrivaled Streaming Lineup, Unveiling 10 New Marquee Channel Partners

NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Sports Studio Inc. today announced a major expansion of its rapidly growing streaming platform, Free Live Sports (FLS), with the addition of 10 new marquee channel partners including NASCAR, Sports Illustrated TV, MSG Sports Zone, Tennis TV, Unbeaten, Waypoint TV, Overtime, Cirque du Soleil, World Surf League

New Market Survey from Xendee Reveals DER Developers are Shifting Project Focus Amidst Federal Funding Losses

LAS VEGAS, Jan. 21, 2026 (GLOBE NEWSWIRE) — Xendee Corporation, provider of the leading design and operation platform for distributed energy and microgrid systems, announced today the results of a new market survey executed by Energy Changemakers and Renewable Energy World that highlights how distributed energy and microgrid projects might be evolving in 2026 following

California K-12 Schools Now Eligible for neffyinSchools Program, Offering Needle-Free Epinephrine at No Cost for Emergency Use

(NasdaqGM:SPRY), California joins 23 other states eligible to receive free neffy(R) (epinephrine nasal spray) at schools SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis, announced today that

Corporate and Municipal CUSIP Request Volumes Decline in December

NORWALK, Conn., Jan. 21, 2026 (GLOBE NEWSWIRE) — CUSIP Global Services (CGS) today announced the release of its CUSIP Issuance Trends Report for December 2025. The report, which tracks the issuance of new security identifiers as an early indicator of debt and capital markets activity over the next quarter, found sharp monthly decreases in request

SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247

(NasdaqGM:SCYX), The QIDP designation will ensure at least 10 years of market exclusivity for SCY-247 following approval Recent articles highlight the growing threat from a rapidly spreading, multi-drug resistant, Candida auris fungal infection JERSEY CITY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and

Vortex Energy Highlights 2025 Technical Milestones Across Project Portfolio and Announces Adjournment of AGM to February 13, 2026

(CNSX:VRTX.CN),(OTC US:VTECF),(Other OTC:VTECF),(Boerse Frankfurt – Freiverkehr:AA3),(Boerse Frankfurt – Freiverkehr:AA3.F),(Frankfurt:AA3I.F), VANCOUVER, British Columbia, Jan. 21, 2026 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company“) is pleased to provide a year-in-review summary of technical milestones achieved in 2025, along with a preview of the Company's exploration plans for 2026.

Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates

(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced a progress update for the Phase 2 B-SUPREME study of pevifoscorvir sodium in subjects with chronic hepatitis B virus

InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026

(NASDAQ:INNV), DENVER, Jan. 21, 2026 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal second quarter financial results on Tuesday,

Manulife to Release Fourth Quarter and Full Year 2025 Results

C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945 Manulife Financial Corporation will release its fourth quarter and full year 2025 financial results after markets close on Wednesday, February 11, 2026, which will be made available at manulife.com/en/investors/results-and-reports. A live webcast and conference call are scheduled for Thursday, February 12, 2026, at 8:00 a.m. (ET) where

Scroll to Top